Summary & Overview
CPT 59012: Fetal Umbilical Cord Blood Sampling for Diagnostic Testing
CPT code 59012 represents percutaneous fetal blood sampling from the umbilical cord using transplacental or transamniotic needle techniques to diagnose fetal blood disorders and infections. As an advanced invasive fetal diagnostic procedure, it is performed by maternal-fetal medicine specialists in facilities equipped for high-risk obstetric interventions. Nationally, this code matters because it captures resource-intensive, specialty prenatal diagnostic care that informs critical clinical decisions about fetal health and perinatal management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the clinical context for CPT code 59012, expected sites of service, and the role of the procedure in diagnosing fetal hematologic and infectious conditions. The publication also summarizes common billing considerations and related policy implications affecting reimbursement and coverage for invasive prenatal diagnostics. Where specific payer policies are available, benchmarking information and policy updates relevant to national coverage practices are summarized.
This resource is intended to help coding, billing, and clinical teams understand the clinical indication and billing classification for CPT code 59012, plus the broader implications for prenatal diagnostic services and perinatal care pathways.
Billing Code Overview
CPT code 59012 describes fetal blood sampling (percutaneous umbilical cord blood sampling) using a needle via transplacental or transamniotic approaches to obtain fetal blood for diagnosis of blood disorders and infections. This procedure is an invasive fetal diagnostic test performed to assess fetal hematologic conditions, infections, and other blood-related abnormalities.
-
Service type: Invasive fetal diagnostic procedure (percutaneous umbilical cord blood sampling)
-
Typical site of service: Hospital operating room, labor and delivery suite, or specialized maternal-fetal medicine unit with appropriate fetal-monitoring and interventional capabilities.
Clinical & Coding Specifications
Clinical Context
A 31-year-old gravida 2 para 1 at 29 weeks gestation is referred to a maternal-fetal medicine service for evaluation of suspected fetal anemia after abnormal middle cerebral artery (MCA) Doppler velocities on ultrasound and a prior history of red-cell alloimmunization (anti-D antibody titer rising). The clinical workflow begins with a targeted obstetric ultrasound to confirm fetal position, placental location, amniotic fluid volume, and to localize the umbilical cord insertion site. Under continuous ultrasound guidance in a sterile procedure suite or operating room with neonatal resuscitation available, the maternal-fetal medicine specialist administers local maternal anesthesia and prepares for percutaneous umbilical blood sampling. Using either a transplacental (through the placenta) or transamniotic (through the amniotic fluid) approach, a fine-gauge needle is advanced into the fetal umbilical vein near the cord insertion to aspirate fetal blood for diagnostic testing (blood type, hemoglobin/hematocrit, platelet count, blood gas, culture, and direct antiglobulin test). Fetal monitoring (ultrasound visualization and fetal heart rate assessment) is continuous during and after needle withdrawal. Specimens are sent to the laboratory immediately; transfusion-ready products are available if intrauterine transfusion is required. Postprocedure observation includes ultrasound assessment for bleeding or hematoma, maternal vital signs monitoring, and fetal surveillance for an appropriate interval prior to discharge or transfer to a higher level of care. Typical sites of service include a maternal-fetal medicine clinic procedure suite, an ambulatory surgery center with appropriate obstetric capabilities, or an operating room in a tertiary care center. The service type is a diagnostic fetal blood sampling procedure performed by a percutaneous umbilical cord approach (CPT 59012).
Coding Specifications
| Modifier | Description |
|---|